Pharmacological Research,
Journal Year:
2023,
Volume and Issue:
196, P. 106916 - 106916
Published: Sept. 9, 2023
In
the
wake
of
development
metagenomic,
metabolomic,
and
metatranscriptomic
approaches,
intricate
interactions
between
host
various
microbes
are
now
being
progressively
understood.
Numerous
studies
have
demonstrated
evident
changes
in
gut
microbiota
during
process
a
variety
diseases,
such
as
diabetes,
obesity,
aging,
cancers.
Notably,
is
viewed
potential
source
novel
therapeutics.
Currently,
Next-generation
probiotics
(NGPs)
gaining
popularity
therapeutic
agents
that
alter
affect
cancer
development.
Akkermansia
muciniphila
(A.
muciniphila),
representative
commensal
bacterium,
has
received
substantial
attention
over
past
decade
promising
NGP.
The
components
metabolites
A.
can
directly
or
indirectly
tumorigenesis,
particular
through
its
effects
on
antitumor
immunosurveillance,
including
stimulation
pattern
recognition
receptors
(PRRs),
which
also
leads
to
better
outcomes
situations,
prevention
curation
this
article,
we
systematically
summarize
role
tumorigenesis
(involving
gastrointestinal
non-gastrointestinal
cancers)
tumor
therapy.
particular,
carefully
discuss
some
critical
scientific
issues
need
be
solved
for
future
using
beneficial
bacterium
treatment,
might
provide
bright
clues
assistance
application
drugs
targeting
clinical
oncotherapy.
Nature Communications,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: March 19, 2025
Akkermansia
muciniphila,
a
promising
candidate
for
next-generation
probiotics,
exhibits
significant
genomic
diversity,
classified
into
several
distinct
clades
(AmI
to
AmIV).
Notably,
single
clade
tends
predominate
within
individual
hosts,
with
co-occurrence
of
different
being
rare.
The
mechanisms
driving
such
clade-specific
exclusion
remain
unclear.
Here,
we
show
that
extracellular
vesicles
(EVs)
derived
from
AmII
inhibit
the
growth
I
(AmI),
conferring
competitive
advantage
AmII.
Moreover,
observe
immunoglobulin
A
(IgA)
responses,
where
IgAs,
induced
by
EVs
AmII,
facilitate
niche
occupancy
and
AmI.
These
findings
provide
insights
dynamics
A.
muciniphila
suggest
future
personalized
microbiome
interventions
could
be
optimized
considering
composition
in
hosts.
Applied and Environmental Microbiology,
Journal Year:
2021,
Volume and Issue:
88(1)
Published: Oct. 20, 2021
Akkermansia
muciniphila
is
a
mucin-degrading
bacterium
found
in
the
human
gut
and
often
associated
with
positive
health.
However,
despite
being
detected
by
as
early
1
month
of
age,
little
known
about
role
infant
gut.
Human
milk
oligosaccharides
(HMOs)
are
abundant
components
structurally
similar
to
that
comprise
mucin,
preferred
growth
substrate
human-associated
Akkermansia.
A
limited
subset
intestinal
bacteria
has
been
shown
grow
well
on
HMOs
mucin.
We
therefore
examined
ability
genomically
diverse
strains
HMOs.
First,
we
screened
85
genomes
representing
four
phylogroups
examine
their
metabolic
potential
degrade
Furthermore,
representative
isolates
individual
mucin
background
analyzed
resulting
metabolites.
All
were
equipped
an
array
glycoside
hydrolases
HMO
deconstruction.
Representative
all
able
various
efficiencies
yields.
Strain
CSUN-19,
belonging
AmIV
phylogroup,
grew
highest
level
presence
fucosylated
sialylated
This
activity
may
be
partially
related
increased
copy
numbers
and/or
enzyme
activities
α-fucosidases,
α-sialidases,
β-galactosidases.
study
examines
utilization
purified
phylogroups.
Further
studies
required
how
ingestion
influences
microbial
ecology
infants
harboring
different
IMPORTANCE
third
most
component
breast
provide
several
benefits
developing
infants,
including
recruitment
beneficial
largely
considered
have
colostrum,
milk,
young
infants.
A.
MucT,
AmI
contributes
deconstruction
capacity
infant.
Here,
using
phylogenomics,
genomic
capacities
deconstruct
Indeed,
each
phylogroup
contained
differences
HMOs,
These
Akkermansia-HMO
interactions
potentially
influence
life,
critical
time
for
development
microbiome
Frontiers in Microbiology,
Journal Year:
2022,
Volume and Issue:
13
Published: May 18, 2022
Clostridioides
difficile
is
a
common
cause
of
nosocomial
infection.
Antibiotic-induced
dysbiosis
in
the
intestinal
microbiota
core
C.
infection
(CDI).
Akkermansia
muciniphila
plays
an
active
role
maintaining
gastrointestinal
balance
and
might
offer
protective
effects
on
CDI
as
probiotics.
Here,
we
investigated
mechanisms
A.
CDI.
C57BL/6
mice
(n
=
29)
were
administered
Muc
T
(3
×
109
CFUs,
0.2
mL)
or
phosphate-buffered
saline
(PBS)
by
oral
gavage
for
2
weeks.
Mice
pretreated
with
antibiotic
cocktail
subsequently
challenged
strain
VPI
10463.
treatment
prevented
weight
loss
reduced
histological
injury
colon.
And
it
also
alleviated
inflammation
improved
barrier
function
intestine.
The
administration
may
be
associated
increase
short-chain
fatty
acid
production
maintenance
bile
acids'
steady-state.
Our
results
provide
evidence
that
to
mice,
imbalance
microbial
community
structure,
lead
decrease
abundance
members
Enterobacteriaceae
Enterococcaceae.
In
short,
shows
potential
anti-CDI
modulating
gut
metabolome.
Science Translational Medicine,
Journal Year:
2022,
Volume and Issue:
14(671)
Published: Nov. 16, 2022
Not
all
patients
with
cancer
and
severe
neutropenia
develop
fever,
the
fecal
microbiome
may
play
a
role.
In
single-center
study
of
undergoing
hematopoietic
cell
transplant
(
n
=
119),
was
characterized
at
onset
neutropenia.
A
total
63
(53%)
developed
subsequent
their
displayed
increased
relative
abundances
Akkermansia
muciniphila
,
species
mucin-degrading
bacteria
P
0.006,
corrected
for
multiple
comparisons).
Two
therapies
that
induce
neutropenia,
irradiation
melphalan,
similarly
expanded
A.
additionally
thinned
colonic
mucus
layer
in
mice.
Caloric
restriction
unirradiated
mice
also
layer.
Antibiotic
treatment
to
eradicate
before
caloric
preserved
mucus,
whereas
reintroduction
restored
thinning.
raised
luminal
pH
reduced
acetate,
propionate,
butyrate.
Culturing
vitro
propionate
utilization
mucin
as
well
fucose.
Treating
irradiated
an
antibiotic
targeting
or
layer,
suppressed
translocation
flagellin,
inflammatory
cytokines
colon,
improved
thermoregulation.
These
results
suggest
diet,
metabolites,
link
neutropenic
fever
guide
future
microbiome-based
preventive
strategies.
Pharmacological Research,
Journal Year:
2023,
Volume and Issue:
196, P. 106916 - 106916
Published: Sept. 9, 2023
In
the
wake
of
development
metagenomic,
metabolomic,
and
metatranscriptomic
approaches,
intricate
interactions
between
host
various
microbes
are
now
being
progressively
understood.
Numerous
studies
have
demonstrated
evident
changes
in
gut
microbiota
during
process
a
variety
diseases,
such
as
diabetes,
obesity,
aging,
cancers.
Notably,
is
viewed
potential
source
novel
therapeutics.
Currently,
Next-generation
probiotics
(NGPs)
gaining
popularity
therapeutic
agents
that
alter
affect
cancer
development.
Akkermansia
muciniphila
(A.
muciniphila),
representative
commensal
bacterium,
has
received
substantial
attention
over
past
decade
promising
NGP.
The
components
metabolites
A.
can
directly
or
indirectly
tumorigenesis,
particular
through
its
effects
on
antitumor
immunosurveillance,
including
stimulation
pattern
recognition
receptors
(PRRs),
which
also
leads
to
better
outcomes
situations,
prevention
curation
this
article,
we
systematically
summarize
role
tumorigenesis
(involving
gastrointestinal
non-gastrointestinal
cancers)
tumor
therapy.
particular,
carefully
discuss
some
critical
scientific
issues
need
be
solved
for
future
using
beneficial
bacterium
treatment,
might
provide
bright
clues
assistance
application
drugs
targeting
clinical
oncotherapy.